Analysis of gene involved in cholesterol metabolism revealed significant downregulation of genes such as HMGCS1, IDI1, HMGCR, SQLE, and FDFT1, following CE treatment (Figures 4F–H), supporting the hypothesis that CE inhibits cholesterol biosynthesis in SCLC cells. The gene discussed is FDFT1; the disease is small cell lung carcinoma.